Step by Stepa HemeOncBuddy patient portal

Lapatinib

Illustration: Lapatinib

Say it: la-PA-tih-nib · Brand names: Tykerb

Lapatinib is a targeted therapy pill that blocks HER2, a protein that helps some breast cancers grow.

What it is

Some breast cancer cells have too much of a protein called HER2. HER2 sends signals that tell cells to grow. Lapatinib blocks these signals from inside the cell, which can slow the cancer.

Often used for

How you get it

Lapatinib is a pill you take by mouth at home, once a day. Take it on an empty stomach, at least 1 hour before or 1 hour after a meal. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Lapatinib?
Lapatinib is a targeted therapy pill that blocks HER2, a protein that helps some breast cancers grow. Brand names: Tykerb.
What is Lapatinib used for?
HER2 positive breast cancer that has spread, given with capecitabine; hormone receptor positive, HER2 positive breast cancer that has spread, given with letrozole.
How is Lapatinib given?
Lapatinib is a pill you take by mouth at home, once a day. Take it on an empty stomach, at least 1 hour before or 1 hour after a meal. Your schedule may be different.
What are the common side effects of Lapatinib?
Diarrhea. Redness, soreness, peeling, or blisters on the palms of your hands or soles of your feet. Feeling sick to your stomach or throwing up. Rash or dry skin. Feeling tired or weak. Mouth sores.
When should I call my care team while taking Lapatinib?
Yellow skin or eyes, dark tea colored urine, or pain on the right side of your belly; Shortness of breath, swelling in your legs, or a racing or uneven heartbeat; Diarrhea that does not get better with the medicine your team gave you, or more than 4 to 6 loose stools in a day; New or worse cough, chest pain, or trouble breathing; A rash with blisters, peeling skin, or sores in your mouth or eyes; Feeling faint or passing out.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.